A bibliometric analysis of alpha-synuclein in Parkinson’s disease from 2015 to 2024
The significance of α-syn in Parkinson's disease research is growing. Future efforts should emphasize mechanistic studies, biomarker validation, and targeted therapies to advance personalized medicine in PD.
Authors
- Danxia Gu
- Xia Liu (ORCID: https://orcid.org/0000-0002-9209-0562)
- Liangman Xiao
- Shumin Lin
- Lixing Zhuang
- Yixuan Wu
- Jingqi Fan
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Guangdong Academy of Sciences (CN)
- First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3389/fneur.2026.1712325
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Guangzhou University of Chinese Medicine
- Guangzhou University
- Basic and Applied Basic Research Foundation of Guangdong Province